so from this latest 'communique' ..."As such we will take additional EPP studies in the northern hemisphere spring to collect further safety and efficacy data".
So the starting date for the confirmatory phase 3 trials is now going to be spring in the northern hemisphere .. in the August 31 release Hank Agersborg was quoted as saying ...
"The six month trial CUV029 will start in five centres across Europe shortly, and it is anticipated that approximately 40 patients will be included in this trial.”
So two things ... 1. In whose universe does seven months equal "shortly" ? 2. The confirmatory trial is now scheduled to completed in September 2010 - ie: 6 months after it starts on March 21 in Europe (traditional start of spring date)...
Anyone else annoyed with the constant delays from these guys .. or are you all immune to it now ?
CUV Price at posting:
$3.05 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)